Skip to main content

Harte Hanks, Inc.

corporate_fare Company Profile

Harte Hanks, Inc.

HHS·NASDAQ·Trade & Services·CIK 0000045919

Harte Hanks, Inc. is a global Business Experience Outsourcing company. The company operates by integrating front office revenue growth and customer experience operations with back office execution, focusing on data, marketing, sales, customer care, fulfillment, and logistics to deliver measurable business outcomes. Harte Hanks serves leading global brands, helping them design, activate, and optimize the full customer and product lifecycle. The company has offices in North America, Asia-Pacific, and Europe. Harte Hanks was incorporated in Delaware on October 1, 1970, succeeding a newspaper business started in Texas in the early 1920s. It went public in 1972, listed on the New York Stock Exchange, became private in 1984, and again went public in 1993, listing common stock on the NYSE. On July 13, 2020, the company began trading on the OTCQX® Best Market. On December 1, 2021, its stock was uplisted to trade on the Nasdaq Global Market®, where it continues to trade.

Harte Hanks, Inc. (NASDAQ:HHS) is a publicly traded company in the Trade & Services sector. Wiseek has independently scored 7 items for HHS at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-13, rated 7/10. Across its 7 most recent items scored 7 or higher, the top rating is 9/10, with 2 rated 8 or above. Recent SEC coverage for HHS spans 10-Q, 8-K, 10-K.

Recent high-impact activity:

  • Harte Hanks Posts $7.1M Nine-Month Loss as Merger Costs Bite; Cash Falls to $2.4M
  • Go-Shop Period Ends Without Superior Proposal; Board Stands Behind Star Merger
  • Harte Hanks to Be Acquired by Star Equity for $5.00/Share — 100% Premium, 30-Day Go-Shop
  • Harte Hanks to Be Acquired by Star Equity for $5.00/Share in Cash or Preferred Stock
  • Harte Hanks Reports Q1 2026 Results: Revenue Down 10.3%, Net Loss Worsens 60.2% Amid Operational Challenges

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$159.57M
Net Income
-$811K
Diluted EPS
-$0.11
Op. Cash Flow
-$1.74M
Free Cash Flow
-$4.49M
Operating Income
$386K
Cash & Equivalents
$5.58M
Debt / Equity
0.00×
Net Margin
-0.5%
Shares Outstanding
7.41M sh
Source: 10-K · filed 2026-03-17 · accession 0001628280-26-018894

Short Interest & Short Volume

1.00 days to cover

FINRA reported short interest of 43,904 shares in HHS as of the October 30, 2026 settlement, a 20.9% increase from the prior period — about 1.0 days to cover at its recent average daily volume. On November 20, 2026, 63.8% of HHS volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)43,904 shares as of October 30, 2026
Change vs prior period▲ 20.9%
Days to cover1.00 at avg daily volume of 56,885
Daily short volume (FINRA facilities)63.8% of 57,051 shares on November 20, 2026
5-day average short volume44.9%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with H →
$3.6
52-week range · as of 2026-11-13 $2 – $4.67
Market cap
$26.84M
Volume
96.3K (2.1× avg)
3-mo avg 46.1K
Live data · 2026-11-21 22:10 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed HHS - Latest Insights

HHS
Nov 13, 2026, 8:46 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $4.03
Real-time Price: $3.60 info
Change: -$0.430 (-11%) info
Market Cap: $26.835M info
HHS
Sep 15, 2026, 4:04 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $4.46
Real-time Price: $3.60 info
Change: -$0.860 (-19%) info
Market Cap: $26.835M info
HHS
Aug 19, 2026, 4:17 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $3.79
Real-time Price: $3.60 info
Change: -$0.190 (-5%) info
Market Cap: $26.835M info
HHS
Aug 14, 2026, 5:08 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $4.22
Real-time Price: $3.60 info
Change: -$0.620 (-15%) info
Market Cap: $26.835M info
HHS
May 15, 2026, 8:16 AM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $2.81
Real-time Price: $3.60 info
Change: +$0.790 (+28%) info
Market Cap: $26.835M info
HHS
May 14, 2026, 4:24 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.81
Real-time Price: $3.60 info
Change: +$0.790 (+28%) info
Market Cap: $26.835M info
HHS
Mar 17, 2026, 5:20 PM EDT
Filing Type: 10-K
Importance Score:
7
Price at Filing: $2.67
Real-time Price: $3.60 info
Change: +$0.930 (+35%) info
Market Cap: $26.835M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets